These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 6883818)

  • 21. Dialysate CA125 levels in stable peritoneal dialysis patients.
    Okada T; Nakao T; Matsumoto H
    Clin Nephrol; 1999 Jan; 51(1):65-6. PubMed ID: 9988153
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum myoglobin in patients on intermittent and continuous ambulatory peritoneal dialysis.
    Feinfeld DA; Verger C; Briscoe AM; Hotchkiss JL; Nurse HM; Merlin F; Nair S; Hart PM
    Clin Nephrol; 1987 Sep; 28(3):144-6. PubMed ID: 3665208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous ambulatory peritoneal dialysis- a new dimension in the treatment of end-stage renal disease.
    Shohat J; Boner G; Rosenfeld J; Waller A; Iaina A; Eliahou HE
    Isr J Med Sci; 1982 Oct; 18(10):1014-8. PubMed ID: 7174268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
    del Peso G; Selgas R; Bajo MA; Fernández de Castro M; Aguilera A; Cirugeda A; Jiménez C
    Adv Perit Dial; 2000; 16():85-9. PubMed ID: 11045267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary experience with continuous ambulatory peritoneal dialysis.
    Rahman M; Haq SA; Haq A
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):52-8. PubMed ID: 7184498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
    Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of intraperitoneal heparin during peritoneal dialysis.
    Furman KI; Gomperts ED; Hockley J
    Clin Nephrol; 1978 Jan; 9(1):15-8. PubMed ID: 630740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of intraperitoneal dialyzate on blood pressure during continuous ambulatory peritoneal dialysis.
    Fleming SJ; Powell J; Baker LR; Cattell WR; Greenwood R
    Clin Nephrol; 1983 Mar; 19(3):132-3. PubMed ID: 6839562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis with cephalothin in peritoneal dialysis.
    Axelrod J; Meyers BR; Hirschman SZ; Stein R
    Arch Intern Med; 1973 Sep; 132(3):368-71. PubMed ID: 4593192
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical pharmacokinetics of furosemide during continuous ambulatory peritoneal dialysis].
    Boutron H; Singlas E; Brocard JF; Charpentier B; Fries D
    Therapie; 1985; 40(3):155-9. PubMed ID: 4012661
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapy of peritonitis in continuing ambulatory peritoneal dialysis].
    Steurer J; Münch R; Kuhlmann U
    Dtsch Med Wochenschr; 1982 May; 107(21):828-30. PubMed ID: 7075506
    [No Abstract]   [Full Text] [Related]  

  • 32. Clindamycin phosphate kinetics in subjects undergoing CAPD.
    Schwartz MT; Kowalsky SF; McCormick EM; Parker MA; Echols RM
    Clin Nephrol; 1986 Dec; 26(6):303-6. PubMed ID: 3802597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of fluconazole in patients undergoing continuous ambulatory peritoneal dialysis.
    Debruyne D; Ryckelynck JP; Moulin M; Hurault de Ligny B; Levaltier B; Bigot MC
    Clin Pharmacokinet; 1990 Jun; 18(6):491-8. PubMed ID: 2354592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
    Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
    Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.
    Somani P; Shapiro RS; Stockard H; Higgins JT
    Clin Pharmacol Ther; 1982 Jul; 32(1):113-21. PubMed ID: 7083725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
    Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.
    Johnson CA; Welling PG; Zimmerman SW
    Nephron; 1984; 38(1):57-61. PubMed ID: 6472532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nocardia asteroides peritonitis during continuous ambulatory peritoneal dialysis.
    Lopes JO; Alves SH; Benevenga JP; Salla A; Tatsch I
    Rev Inst Med Trop Sao Paulo; 1993; 35(4):377-9. PubMed ID: 8115800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
    Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
    Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience with continuous ambulatory peritoneal dialysis].
    Ferenczi S; Láng L; Németh L; Nagy L
    Orv Hetil; 1985 May; 126(20):1211-2, 1215-6. PubMed ID: 4011220
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.